Health ❯Obesity

Diabetes

China Market Treatment Options Prescription Medications Type 2 Diabetes Genetics and Health Pharmaceutical Treatments Clinical Studies Heart Failure

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

The trial showed 15.7% average weight loss over 68 weeks, below expectations and earlier trial results, causing a significant drop in stock value.

Nestle Introduces Protein Shot to Support Weight Loss and Hunger Management

Novo Nordisk's Weight-Loss Drugs Boost Danish Economy Amid Local Health Challenges

Ancient Gene Duplication Enhanced Human Starch Digestion

Wegovy Shows Promising Results in Heart Failure and Diabetes Treatment